These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 352712)

  • 1. Generation and release of eosinophil chemotactic factor from human polymorphonuclear neutrophils by arachidonic acid.
    König W; Tesch H; Frickhofen N
    Eur J Immunol; 1978 Jun; 8(6):434-7. PubMed ID: 352712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophil chemotactic factor. Release from human polymorphonuclear neutrophils by arachidonic acid.
    Tesch H; König W; Frickhofen N
    Int Arch Allergy Appl Immunol; 1979; 58(4):436-46. PubMed ID: 35469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and secretion of eosinophilotactic activity from human polymorphonuclear neutrophils by various mechanisms of cell activation.
    König W; Frickhofen N; Tesch H
    Immunology; 1979 Apr; 36(4):733-42. PubMed ID: 437847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophils chemotactic factor (ECF). IV. Inhibitory activity in human peripheral leukocytes.
    Czarnetzki BM; König W; Lichtenstein LM
    Int Arch Allergy Appl Immunol; 1978; 56(5):398-408. PubMed ID: 344231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophil chemotactic factor (ECF). I. Release from polymorphonuclear leukocytes by the calcium ionophore A23187.
    Czarnetzki BM; König W; Lichtenstein LM
    J Immunol; 1976 Jul; 117(1):229-34. PubMed ID: 778263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcellular localization of the eosinophil chemotactic factor (ECF) and its inactivator in human polymorphonuclear leucocytes (PMN).
    Frickhofen N; König W
    Immunology; 1979 May; 37(1):111-22. PubMed ID: 468298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophil chemotactic factor (ECF). II. Release from human polymorphonuclear leukocytes during phagocytosis.
    König W; Czarnetzki BM; Lichtenstein LM
    J Immunol; 1976 Jul; 117(1):235-41. PubMed ID: 932426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and release of eosinophil chemotactic factor from human polymorphonuclear leukocytes.
    König W; Czarnetzki BM; Lichtenstein LM
    Monogr Allergy; 1977; 12():198-212. PubMed ID: 335215
    [No Abstract]   [Full Text] [Related]  

  • 9. Generation of leukotrienes and lipoxygenase factors from human polymorphonuclear granulocytes during bacterial phagocytosis and interaction with bacterial exotoxins.
    Bremm KD; Brom J; König W; Spur B; Crea A; Bhakdi S; Lutz F; Fehrenbach FJ
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Jul; 254(4):500-14. PubMed ID: 6326424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the eosinophil chemotactic factor (ECF) release from various cells and their subcellular components by phospholipids.
    König W; Kroegel C; Pfeiffer P; Tesch H
    Int Arch Allergy Appl Immunol; 1981; 65(4):417-31. PubMed ID: 6788714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediation of leukocyte components of inflammatory reactions by lipoxygenase products of arachidonic acid.
    Goetzl EJ; Goldman DW; Naccache PH; Sha'afi RI; Pickett WC
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():273-82. PubMed ID: 6283846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospholipase A2 and arachidonic acid: a common link in the generation of the eosinophil chemotactic factor (ECF) from human PMN by various stimuli.
    Tesch H; König W
    Scand J Immunol; 1980; 11(4):409-18. PubMed ID: 6770461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of human eosinophil polymorphonuclear leukocyte migration and function.
    Goetzl EJ
    Am J Pathol; 1976 Nov; 85(2):419-36. PubMed ID: 793410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low molecular weight eosinophil chemotactic factor (ECF) production by rat peritoneal mononuclear phagocytes.
    Czarnetzki BM
    Immunobiology; 1980 Apr; 157(1):62-6. PubMed ID: 6782008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotactic and chemokinetic stimulation of human eosinophil and neutrophil polymorphonuclear leukocytes by 12-L-hydroxy-5,8,10-heptadecatrienoic acid (HHT).
    Goetzl EJ; Gorman RR
    J Immunol; 1978 Feb; 120(2):526-31. PubMed ID: 621391
    [No Abstract]   [Full Text] [Related]  

  • 16. Eosinophil polymorphonuclear leukocyte function in immediate hypersensitivity.
    Goetzl EJ; Wasserman SI; Austen F
    Arch Pathol; 1975 Jan; 99(1):1-4. PubMed ID: 234219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of polymorphonuclear-neutrophil derived eosinophil chemotactic factor by human serum.
    König W; Czarnetzki BM
    Int Arch Allergy Appl Immunol; 1978; 57(5):399-410. PubMed ID: 352966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of eosinophil chemotactic factor from human polymorphonuclear neutrophils by calcium ionophore A23187 and phagocytosis.
    Gzarnetzki BM; Konig W; Lichtenstein LM
    Nature; 1975 Dec; 258(5537):725-6. PubMed ID: 1107852
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of a novel and highly potent eosinophil chemotactic lipid in human eosinophils treated with arachidonic acid.
    Morita E; Schröder JM; Christophers E
    J Immunol; 1990 Mar; 144(5):1893-900. PubMed ID: 2155268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid.
    Goetzl EJ; Woods JM; Gorman RR
    J Clin Invest; 1977 Jan; 59(1):179-83. PubMed ID: 830662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.